First, apologies if this question is posted elsewhere, but I could not find an answer to my question.
I am using the DESeq normalization procedure on a set of 100 mRNA-Seq samples aligned with STAR and counted with htseq-count. I noticed in the normalization procedure that only genes where all samples have non-zero counts are used in the calculation of size factors. This means that only 15k/52k of my detected genes are used for this calculation, while 21k/52k genes have 5 or fewer zero counts. If I modify the normalization routine to include these extra genes by omitting the zero counts from the geometric mean calculation, the size factors change, where some samples increase, others decrease, and others remain the same. The relative order of the samples by size factor also changes. Overall, the size factors get smaller when increasing numbers of zeros are included, which I think makes sense given that more lowly expressed genes are included but I'm not entirely sure. Analyzing the normalized counts while allowing genes with zeros to be included modestly changes downstream DE results, but I haven't seen any red flags yet so I won't post any examples.
My question: besides numerical reasons, what is the rationale for omitting genes that have even a single zero count? My feeling is that omitting any samples with zero counts biases the normalization to use only genes with high expression and does not take into account lowly, but confidently, expressed genes. Since I have so many samples, I worry this strategy might too severely penalize genes with outlier counts of zero. Is there danger in modifying the routine to allow, say, at most 5/100 samples to have zeros?
Thanks.
I am using the DESeq normalization procedure on a set of 100 mRNA-Seq samples aligned with STAR and counted with htseq-count. I noticed in the normalization procedure that only genes where all samples have non-zero counts are used in the calculation of size factors. This means that only 15k/52k of my detected genes are used for this calculation, while 21k/52k genes have 5 or fewer zero counts. If I modify the normalization routine to include these extra genes by omitting the zero counts from the geometric mean calculation, the size factors change, where some samples increase, others decrease, and others remain the same. The relative order of the samples by size factor also changes. Overall, the size factors get smaller when increasing numbers of zeros are included, which I think makes sense given that more lowly expressed genes are included but I'm not entirely sure. Analyzing the normalized counts while allowing genes with zeros to be included modestly changes downstream DE results, but I haven't seen any red flags yet so I won't post any examples.
My question: besides numerical reasons, what is the rationale for omitting genes that have even a single zero count? My feeling is that omitting any samples with zero counts biases the normalization to use only genes with high expression and does not take into account lowly, but confidently, expressed genes. Since I have so many samples, I worry this strategy might too severely penalize genes with outlier counts of zero. Is there danger in modifying the routine to allow, say, at most 5/100 samples to have zeros?
Thanks.
Comment